An alternative explanation is that during treatment with an anti-TNF agent, a new Mtb infection occurred (plausible in TB endemic countries), resulting in inadequate control of the initial infection and the recruitment of other cell types such as neutrophils, resulting in caseating necrosis of the poorly protective granulomas. Here, TNF is linked to tuberculosis.